Experimental vaccine trial aims to train immune system to fight childhood brain cancer
Disease control
Terminated
This early-stage study tested whether a personalized vaccine-like treatment could safely trigger immune responses against recurrent ependymoma brain tumors in children. The treatment combined tumor-specific protein fragments with an immune-boosting cream. The trial enrolled 23 ch…
Phase: PHASE1 • Sponsor: James Felker • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC